DNA fault detection and error correction platform to diagnose, prevent, and treat diseases associated with the loss of genetic information
Location: United States
Total raised: $7M
Investors 1
| Date | Name | Website |
| - | quadraScop... | quadrascop... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 29.05.2024 | Seed | $7M | - |
Mentions in press and media 3
| Date | Title | Description |
| 29.05.2024 | Matter Bio Closes $7M in Seed Funding | Matter Bio, a NYC-based biotech company dedicated to preserving genome integrity and extending healthy human lifespan, raised $7M in Seed funding. The round was led by Lifespan Vision Ventures, with participation from quadraScope Ventures a... |
| 23.10.2023 | Matter Bio Receives Investment From LifeSpan Vision Ventures | Matter Bio, a NYC-based longevity holding company focused on preserving genome integrity, received an investment from LifeSpan Vision Ventures. The amount of the deal was not disclosed. The company intends to use the funds to initiate clini... |
| - | Matter Bio | “Homepage - matterbio” |